FIGURE

Fig. 2

ID

ZDB-FIG-160525-41

Publication

Sulaiman et al., 2016 - A novel small molecule ameliorates ocular neovascularisation and synergises with anti-VEGF therapy

Other Figures

Fig. 2

All Figure Page

Back to All Figure Page

Fig. 2

SH-11037 significantly inhibits ocular developmental angiogenesis in zebrafish larvae.

(a) Representative epi-fluorescence images of hyaloid vessel (HV) morphology on lenses dissected from drug-treated 5 days post fertilisation (dpf) Tg(fli1:EGFP) larvae. A significant reduction in primary HV branch number is observed at 10 µM SH-11037 (white arrows), scale bars = 50 µm. (b) Representative bright-field images of 5 dpf larval morphology following SH-11037 treatment. Some larvae treated with 10 µM SH-11037 demonstrated pericardial and yolk sac oedema. Scale bars = 500 µm. (c) Quantification of the dose-dependent inhibition of primary HV development in 5 dpf Tg(fli1:EGFP) larvae treated from 2 dpf with 1-10 µM SH-11037. (d) Quantification of the dose-dependent inhibition of SH-11037 on number of hyaloid vessel branches in treated larvae compared to DMSO control. Up to a 40% reduction in primary HV and vessel branches is observed in response to 10 µM SH-11037. ***P <0.01, ***P < 0.001, one-way ANOVA with Dunnett’s post hoc tests. Mean ± s.e.m., n ≥ 3.

Expression Data

Gene:	EGFP
Fish:	y1Tg
Condition:	chemical treatment: SH-11037
Anatomical Term:	hyaloid vessel
Stage:	Day 5

Expression Detail

Antibody Labeling

Phenotype Data

Fish:	y1Tg
Condition:	chemical treatment: SH-11037
Observed In:	hyaloid vessel hyaloid vessel angiogenesis pericardium yolk
Stage:	Day 5

Phenotype Detail

Acknowledgments

This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image. Full text @ Sci. Rep.